The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

DK Graham, D DeRyckere, KD Davies… - Nature Reviews Cancer, 2014 - nature.com
The TYRO3, AXL (also known as UFO) and MERTK (TAM) family of receptor tyrosine
kinases (RTKs) are aberrantly expressed in multiple haematological and epithelial …

Giving AXL the axe: targeting AXL in human malignancy

CM Gay, K Balaji, LA Byers - British journal of cancer, 2017 - nature.com
The receptor tyrosine kinase AXL, activated by a complex interaction between its ligand
growth arrest-specific protein 6 and phosphatidylserine, regulates various vital cellular …

Mir-34: a new weapon against cancer?

G Misso, MT Di Martino, G De Rosa, AA Farooqi… - … therapy-nucleic acids, 2014 - cell.com
The microRNA (miRNA)-34a is a key regulator of tumor suppression. It controls the
expression of a plethora of target proteins involved in cell cycle, differentiation and …

EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer

E Tulchinsky, O Demidov, M Kriajevska… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Epithelial mesenchymal transition (EMT) is a reversible developmental genetic programme
of transdifferentiation of polarised epithelial cells to mesenchymal cells. In cancer, EMT is an …

Macrophage‐mediated tumor cell phagocytosis: opportunity for nanomedicine intervention

X Zhou, X Liu, L Huang - Advanced functional materials, 2021 - Wiley Online Library
Macrophages are one of the most abundant non‐malignant cells in the tumor
microenvironment, playing critical roles in mediating tumor immunity. As important innate …

The p53/miR-34 axis in development and disease

M Rokavec, H Li, L Jiang… - Journal of molecular cell …, 2014 - academic.oup.com
The tumor suppressor p53 is one of the most frequently mutated genes in human cancers.
MicroRNAs (miRNAs) are small non-protein coding RNAs that regulate gene expression on …

[HTML][HTML] AXL kinase as a novel target for cancer therapy

X Wu, X Liu, S Koul, CY Lee, Z Zhang, B Halmos - Oncotarget, 2014 - ncbi.nlm.nih.gov
The AXL receptor tyrosine kinase and its major ligand, GAS6 have been demonstrated to be
overexpressed and activated in many human cancers (such as lung, breast, and pancreatic …

Breast cancer stem cells, EMT and therapeutic targets

S Kotiyal, S Bhattacharya - Biochemical and biophysical research …, 2014 - Elsevier
A small heterogeneous population of breast cancer cells acts as seeds to induce new tumor
growth. These seeds or breast cancer stem cells (BCSCs) exhibit great phenotypical …

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1

S Yang, Y Li, J Gao, T Zhang, S Li, A Luo, H Chen… - Oncogene, 2013 - nature.com
MicroRNAs have key roles in tumor metastasis. Here, we describe the regulation and
function of miR-34a and miR-34c (miR-34a/c) in breast cancer metastasis. Expression …

The receptor tyrosine kinase AXL in cancer progression

EB Rankin, AJ Giaccia - Cancers, 2016 - mdpi.com
The AXL receptor tyrosine kinase (AXL) has emerged as a promising therapeutic target for
cancer therapy. Recent studies have revealed a central role of AXL signaling in tumor …